BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leblanc F, Fonck M, Brunet R, Becouarn Y, Mathoulin-Pélissier S, Evrard S. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. Eur J Surg Oncol. 2008;34:185-190. [PMID: 17998155 DOI: 10.1016/j.ejso.2007.09.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Bhutiani N, Bruenderman EH, Jones JM, Wehry JH, Egger ME, Philips P, Scoggins CR, McMasters KM, Martin RCG. A literature-based treatment algorithm for low-grade neuroendocrine liver metastases. HPB (Oxford) 2021;23:63-70. [PMID: 32448647 DOI: 10.1016/j.hpb.2020.04.012] [Reference Citation Analysis]
2 Gurusamy KS, Ramamoorthy R, Sharma D, Davidson BR, Gurusamy KS. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007060] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Weng M, Zhang Y, Zhou D, Yang Y, Tang Z, Zhao M, Quan Z, Gong W. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One. 2012;7:e45493. [PMID: 23029051 DOI: 10.1371/journal.pone.0045493] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
4 Li D, Kang J, Golas BJ, Yeung VW, Madoff DC. Minimally invasive local therapies for liver cancer. Cancer Biol Med. 2014;11:217-236. [PMID: 25610708 DOI: 10.7497/j.issn.2095-3941.2014.04.001] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
5 Evrard S. Limits of colorectal liver metastases resectability: how and why to overcome them? For progress in cancer research. Recent Results Cancer Res 2014;203:213-29. [PMID: 25103008 DOI: 10.1007/978-3-319-08060-4_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Xourafas D, Pawlik TM, Ejaz A, Dillhoff M, Abdel-misih S, Tsung A, Cloyd JM. Impact of concomitant ablation on the perioperative outcomes of patients with colorectal liver metastases undergoing hepatectomy: a propensity score matched nationwide analysis. HPB 2019;21:1079-86. [DOI: 10.1016/j.hpb.2018.12.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
7 Govaert KM, van Kessel CS, Lolkema M, Ruers TJ, Borel Rinkes IH. Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases? Curr Colorectal Cancer Rep. 2012;8:130-137. [PMID: 22611343 DOI: 10.1007/s11888-012-0122-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gurusamy KS, Ramamoorthy R, Imber C, Davidson BR. Surgical resection versus non-surgical treatment for hepatic node positive patients with colorectal liver metastases. Cochrane Database Syst Rev 2010;:CD006797. [PMID: 20091607 DOI: 10.1002/14651858.CD006797.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
9 Tan HL, Lee M, Vellayappan BA, Neo WT, Yong WP. The Role of Liver-Directed Therapy in Metastatic Colorectal Cancer. Curr Colorectal Cancer Rep. 2018;14:129-137. [PMID: 30294248 DOI: 10.1007/s11888-018-0409-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Desolneux G, Vara J, Razafindratsira T, Isambert M, Brouste V, McKelvie-Sebileau P, Evrard S. Patterns of complications following intraoperative radiofrequency ablation for liver metastases. HPB (Oxford) 2014;16:1002-8. [PMID: 24830798 DOI: 10.1111/hpb.12274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
11 Torres-Jiménez J, Esteban-Villarrubia J, Ferreiro-Monteagudo R, Carrato A. Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist. Cancers (Basel) 2021;13:5938. [PMID: 34885047 DOI: 10.3390/cancers13235938] [Reference Citation Analysis]
12 Gurusamy KS, Ramamoorthy R, Sharma D, Davidson BR. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Cochrane Database Syst Rev. 2009;CD007060. [PMID: 19370671 DOI: 10.1002/14651858.cd007060.pub2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
13 Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, Noya G, Abraha I. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;6:CD006317. [PMID: 22696357 DOI: 10.1002/14651858.cd006317.pub3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
14 Evrard S. [Intraoperative radiofrequency ablation of liver metastases: age of reason]. Bull Cancer 2010;97:91-6. [PMID: 20007068 DOI: 10.1684/bdc.2009.1018] [Reference Citation Analysis]
15 Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol. 2014;5:374-387. [PMID: 25276410 DOI: 10.3978/j.issn.2078-6891.2014.064] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
16 Li D, Kang J, Madoff DC. Locally ablative therapies for primary and metastatic liver cancer. Expert Rev Anticancer Ther. 2014;14:931-945. [PMID: 24746315 DOI: 10.1586/14737140.2014.911091] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
17 Penchev DK, Vladova LV, Zashev MZ, Gornev RP. Distant Liver Metastases as a Major Factor Influencing Survival in Patients with Colorectal Cancer. Folia Med (Plovdiv) 2016;58:182-7. [PMID: 27760013 DOI: 10.1515/folmed-2016-0023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Evrard S, Rivoire M, Arnaud J, Lermite E, Bellera C, Fonck M, Becouarn Y, Lalet C, Pulido M, Mathoulin-pelissier S. Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection19. British Journal of Surgery 2012;99:558-65. [DOI: 10.1002/bjs.8665] [Cited by in Crossref: 53] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
19 Wang J, Liang P, Yu J, Yu MA, Liu F, Cheng Z, Yu X. Clinical outcome of ultrasound-guided percutaneous microwave ablation on colorectal liver metastases. Oncol Lett 2014;8:323-6. [PMID: 24959270 DOI: 10.3892/ol.2014.2106] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
20 Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, Beppu T, Iwashita Y, Wada K, Nakajima TE, Sakamoto K, Hayano K, Mori Y, Asai K, Matsuyama R, Hirashita T, Hibi T, Sakai N, Tabata T, Kawakami H, Takeda H, Mizukami T, Ozaka M, Ueno M, Naito Y, Okano N, Ueno T, Hijioka S, Shikata S, Ukai T, Strasberg S, Sarr MG, Jagannath P, Hwang TL, Han HS, Yoon YS, Wang HJ, Luo SC, Adam R, Gimenez M, Scatton O, Oh DY, Takada T. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci 2021;28:1-25. [PMID: 33200538 DOI: 10.1002/jhbp.868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Pathak S, Jones R, Tang JM, Parmar C, Fenwick S, Malik H, Poston G. Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis. 2011;13:e252-e265. [PMID: 21689362 DOI: 10.1111/j.1463-1318.2011.02695.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 11.0] [Reference Citation Analysis]
22 Joo I. The role of intraoperative ultrasonography in the diagnosis and management of focal hepatic lesions. Ultrasonography 2015;34:246-57. [PMID: 25971896 DOI: 10.14366/usg.15014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
23 Lesurtel M, Nagorney DM, Mazzaferro V, Jensen RT, Poston GJ. When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations. HPB (Oxford). 2015;17:17-22. [PMID: 24636662 DOI: 10.1111/hpb.12225] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
24 Mahnken AH, Pereira PL, de Baère T. Interventional oncologic approaches to liver metastases. Radiology 2013;266:407-30. [PMID: 23362094 DOI: 10.1148/radiol.12112544] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.0] [Reference Citation Analysis]
25 Ou S, Xu R, Li K, Chen Y, Kong Y, Liu H, Li J, Ouyang Y, Yu X. Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study. Cancer Manag Res 2018;10:5227-37. [PMID: 30464620 DOI: 10.2147/CMAR.S170160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
26 de Baere T. Traitement des métastases hépatiques par radiofréquence. Cancer/Radiothérapie 2012;16:339-43. [DOI: 10.1016/j.canrad.2012.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Evrard S, Poston G, Kissmeyer-Nielsen P, Diallo A, Desolneux G, Brouste V, Lalet C, Mortensen F, Stättner S, Fenwick S, Malik H, Konstantinidis I, DeMatteo R, D'Angelica M, Allen P, Jarnagin W, Mathoulin-Pelissier S, Fong Y. Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. PLoS One 2014;9:e114404. [PMID: 25485541 DOI: 10.1371/journal.pone.0114404] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
28 Otto G, Düber C, Hoppe-Lotichius M, König J, Heise M, Pitton MB. Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery. Ann Surg. 2010;251:796-803. [PMID: 19858704 DOI: 10.1097/sla.0b013e3181bc9fae] [Cited by in Crossref: 88] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
29 Wu YZ, Li B, Wang T, Wang SJ, Zhou YM. Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: A meta-analysis. World J Gastroenterol 2011; 17(36): 4143-4148 [PMID: 22039331 DOI: 10.3748/wjg.v17.i36.4143] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
30 Gravante G, Overton J, Sorge R, Bhardwaj N, Metcalfe MS, Lloyd DM, Dennison AR. Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg. 2011;15:378-387. [PMID: 21061179 DOI: 10.1007/s11605-010-1377-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
31 Vogl TJ, Farshid P, Naguib NN, Darvishi A, Bazrafshan B, Mbalisike E, Burkhard T, Zangos S. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014;119:451-461. [PMID: 24894923 DOI: 10.1007/s11547-014-0415-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
32 Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011;11:23-30. [PMID: 21435988 DOI: 10.1102/1470-7330.2011.0004] [Cited by in F6Publishing: 8] [Reference Citation Analysis]